FILTERED RESULTS
FILTERS
Ads Top
DARK MODE
CHART
    Filters
      Symbols
      Sentiment
      Impact
      Search
      FILTERED RESULTS

        

      Upgrade your plan

      Evercore ISI Adjusts Price Target for AbbVie Inc.

      Evercore ISI has revised its price target for AbbVie Inc., lowering it slightly from $233 to $232. Despite this adjustment, the firm maintains an Outperform rating on the pharmaceutical company's shares.

      The change in price target was made in conjunction with an update of estimates in a preview note for the first quarter. AbbVie Inc. is also featured in the Early Retirement Portfolio, which highlights the top 15 stocks to buy.

      © 2026 KLEA News. All Rights Reserved. This article is provided for informational purposes only. It is not offered or intended to be used as legal, tax, investment, financial, or other advice.

      Source: KLEA News

      .

      Terra Founder Do Kwon Sentenced to 15 Years in Prison for Fraud